BSE filing, BSE: 544687. Summary written from the filing by ALFA Finder's alert engine.
Hannah Joseph Hospital Ltd: key numbers
- Share price
- ₹99.20
- Market cap
- ₹225.2 Cr
- Revenue (annual)
- ₹92.05 Cr
- Net profit (annual)
- ₹11.18 Cr
- P/E (TTM)
- 20.1×Sector 51.1×
- Promoter holding
- 71.50%
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hannah Joseph Hospital Ltd
All →Hannah Joseph Hospital Business Update
Hannah Joseph Hospital received the 'Honours for Healthcare Excellence in Neurosciences' at CII TN MedClave 2026. The award recognises its multidisciplinary Neurosciences services in Tamil Nadu.
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital Limited through an open market purchase. This transaction increases the total promoter group stake to 71.502%.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
- From
- Confederation of Indian Industry (CII)
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the AHPI-TN Excellence Award 2026 for Best Single Hospital (above 100 beds) in the Central Zone. This industry recognition highlights its service quality.
Hannah Joseph Hospital Promoter Buying
Daniel Dayanand Fenn, a promoter of Hannah Joseph Hospital Limited, acquired 2,000 equity shares via the open market. This transaction increased the promoter group stake to 71.484%.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.